← Browse by Condition
Medical Condition

hormone receptor positive hr her2 negative breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06805812
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Enrollment
3,500 pts
Location
Italy
Sponsor
Fondazione IRCCS Istituto Nazi...
View Trial →